CytomX Therapeutics, Inc. - stock earnings
CTMX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 837000 USD | 26.6 million USD |
| 2023Q3 | 3.0 million USD | 26.4 million USD |
| 2023Q2 | -1.1 million USD | 24.7 million USD |
| 2023Q1 | -969000 USD | 23.5 million USD |
| 2022Q4 | -26.6 million USD | 946000 USD |
| 2022Q3 | -22.7 million USD | 16.9 million USD |
| 2022Q2 | -23.6 million USD | 18.2 million USD |
| 2022Q1 | -23.8 million USD | 17.1 million USD |
| 2021Q4 | -26.2 million USD | 19.7 million USD |
| 2021Q3 | -22.6 million USD | 17.6 million USD |
| 2021Q2 | -19.2 million USD | 16.3 million USD |
| 2021Q1 | -15.6 million USD | 16.0 million USD |
| 2020Q4 | -14.7 million USD | 16.4 million USD |
| 2020Q3 | -14.7 million USD | 17.8 million USD |
| 2020Q2 | -15.7 million USD | 16.6 million USD |
| 2020Q1 | 12.2 million USD | 49.6 million USD |
| 2019Q4 | -35.5 million USD | 8.3 million USD |
| 2019Q3 | -23.7 million USD | 10.7 million USD |
| 2019Q2 | -29.0 million USD | 9.0 million USD |
| 2019Q1 | -14.1 million USD | 29.5 million USD |
| 2018Q4 | -32.2 million USD | 11.5 million USD |
| 2018Q3 | -23.4 million USD | 12.5 million USD |
| 2018Q2 | -13.4 million USD | 21.3 million USD |
| 2018Q1 | -15.5 million USD | 14.2 million USD |
| 2017Q4 | 621000 USD | 27.1 million USD |
| 2017Q3 | -10.2 million USD | 24.1 million USD |
| 2017Q2 | -25.2 million USD | 8.8 million USD |
| 2017Q1 | -8.3 million USD | 11.7 million USD |
| 2016Q4 | -14.0 million USD | 6.3 million USD |
| 2016Q3 | -14.7 million USD | 3.5 million USD |
| 2016Q2 | -14.2 million USD | 3.1 million USD |
| 2016Q1 | -16.0 million USD | 2.2 million USD |
| 2015Q4 | -11.5 million USD | 2.0 million USD |
| 2015Q3 | -11.9 million USD | 1.9 million USD |
| 2015Q2 | -5.8 million USD | 2.0 million USD |
| 2015Q1 | -6.2 million USD | 1.7 million USD |
| 2014Q4 | -4.8 million USD | 1.9 million USD |
| 2014Q3 | -3.6 million USD | 1.9 million USD |
| 2014Q2 | ? USD | 1.3 million USD |
| 2013Q4 | ? USD | 888000 USD |
CTMX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -569000 USD | 101.2 million USD |
| 2022 | -97.3 million USD | 53.2 million USD |
| 2021 | -80.6 million USD | 69.6 million USD |
| 2020 | -32.9 million USD | 100.4 million USD |
| 2019 | -102.2 million USD | 57.5 million USD |
| 2018 | -84.6 million USD | 59.5 million USD |
| 2017 | -43.1 million USD | 71.6 million USD |
| 2016 | -58.9 million USD | 15.0 million USD |
| 2015 | -35.4 million USD | 7.7 million USD |
| 2014 | -30.3 million USD | 5.1 million USD |
| 2013 | -15.1 million USD | 888000 USD |
CTMX
Price: $5.13
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -10.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 865300
Ebitda: -10.5 millionMarket Capitalization: 142.9 million